A single amino acid substitution, Asp-63 to was (3, 4) , the location of regions on the three-dimensional structure of the HA to which antibodies bind have been proposed in the HA of the 1968 influenza virus (5, 6).
Neutralizing antibodies against influenza virus are directed at the hemagglutinin glycoprotein, HA, of the virus membrane (1) . Amino acid sequence variations resulting in altered antigenic properties of the HA accompany the recurrent epidemics of influenza respiratory disease in man. By combining data from amino acid sequence analyses of HAs of viruses that have caused epidemics (for review, see ref. 2) and from analyses of single amino acid substitutions in the HAs of antigenic variants selected by growing virus in the presence of monoclonal antibodies against the HA (3, 4) , the location of regions on the three-dimensional structure of the HA to which antibodies bind have been proposed in the HA of the 1968 influenza virus (5, 6) .
In these studies, it was noted (5, 6 ) that in some viruses of both the Hong Kong (H3) subtype and of other subtypes oligosaccharide attachment sites (Asn-X-Ser/Thr) were present in regions of the HA implicated in antibody binding in the 1968 HA, and this was subsequently observed in a study of a HA of the H1 subtype (7, 8) . Since oligosaccharide chains are host specific and therefore presumably not immunogenic in an infected organism, the possibility was considered that carbohydrate might modulate the antigenic structure of the HA by masking regions of the protein from recognition by antibody.
Here direct evidence is presented that the addition of carbohydrate to the 1968 HA blocks recognition by a monoclonal antibody directed at the region near amino acid residue 63 of the HA. These observations were made for the HAs of antigenic variants of the 1968 Hong Kong virus either isolated from influenza virus-infected humans in 1969 or selected by growth of the 1968 virus, X-31, in eggs in the presence of the monoclonal antibody.
MATERIALS AND METHODS
Viruses. The X-31 (H3N2) recombinant influenza virus (9) and the 1969 isolate A/England/878/69 (H3N2) were used. Viruses were grown in hens' eggs and antigenic variants of X-31 were isolated by mixing equal volumes of allantoic fluid containing wild-type virus and undiluted ascitic fluid containing monoclonal antibodies and using the mixture as inoculum. Variants obtained were cloned by limit dilution.
Hemagglutination-Inhibition Tests. These tests were done by standard methods (10) , using anti-HA monoclonal antibodies and 1% turkey erythrocytes.
Monoclonal Antibody Production. BALB/c mice were immunized by intraperitoneal injection of 8000 HA units of purified X-31 virus. Eight weeks later they received 32,000 HA units of virus intraperitoneally and intravenously. Three days later, their spleens were removed and the cells were fused with SP2/0-Agl4 myeloma cells (11) as described by Kohler and Milstein (12, 13) . Hybrid cell culture conditions were based on those described by Fazekas de St. Groth and Scheidegger (14) . The antibodies produced from different cloned cells were named hemagglutinin clones (HC) and numbered according to the culture number-e.g., the antibodies used in this study for immunoprecipitation were numbered HC31 and HC100. When antibodies have been characterized by determining the sequence of the HA genes of antigenic variants that they select, they are given another number in parentheses. ThUs, HC31, which selects variants with amino acid substitutions at amino acid residue 198, is finally denoted by HC31(198) , and HC100, which selects variants with substitutions at amino acid residue 63, is denoted by HC100(63). The variants selected by these particular antibodies are numbered V31 and V100.
Nucleotide Sequence Analyses. Sequences were determined by using the dideoxynucleotide (ddNTP) chain-terminating procedure (15) . Each 
Inuiunoprecipitation of Infected-Cell Extracts. Cell fractionation. Six hours after infection with virus, primary chicken embryo fibroblasts were suspended in 10 mM Tris-HCl, pH 8.0/1 mM EDTA and disrupted in a Dounce homogenizer (type A, Kontes). After centrifuging at 1000 x g for 10 min, the supernatant was made 70% (wt/vol) in sucrose and overlayed with 3 ml of 55%, 3 ml of 35%, and 3 ml of 1% sucrose in 10 mM Tris-HCl, pH 8.0/1 mM EDTA. This discontinuous gradient was then centrifuged at 35,000 rpm for 60 min in an SW-27 Beckman rotor. The pellets obtained were resuspended in 10 mM Tris-HCl, pH 8.0, containing 100 mM NaCl, 1 mM EDTA, 0.25% gelatin, and 0.5% Nonidet P-40.
Immunoprecipitation. Staphylococcus aureus Cowan strain A cells were washed by cerntrifugation in 5 mM sodium phosphate, pH 7.2, containing 1% Nonidet P-40. Cell fractions were made 10% vol/vol with S. aureus cells and incubated at 4°C for 30 min, and the cells were removed by centrifugation at 10,000 rpm for 1 min. Monoclonal antibody preparations were mixed with supernatants for 60 min at 20°C and then the mixture was made 1% in S. aureus cells and incubated at 4°C for 60 min. The S. aureus cells were washed three times by centrifugation with 10 mM sodium phosphate, pH 7.2/1 mM EDTA/1% Triton X-100/0.1% sodium dodecyl sulfate/0.65 M NaCl and once in the same solution containing 0.15 M NaCl. The final pellet was boiled in 10 M urea/1% sodium dodecyl sulfate/0.1% 2-mercaptoethanol/1 mM Tris H3PO4, pH 6.7, for 2 min and the S. aureus cells were then removed by centrifuging and the supernatant was analyzed by polyacrylamide gel electrophoresis as described (18) .
RESULTS
Monoclonal Antibody-Selected Variant. A variant of X-31 virus that is not neutralized by the mouse monoclonal antibody HC100(63), prepared from mice immunized with X-31 virus, was selected by growth of X-31 in the presence of HC100 (63) Fig. 2 ). This indicates that HC100(63) antibodies recognize the wild-type region of this HA near amino acid residue 63 independently of whether or not the HA is glycosylated.
In summary, Fig. 2 demonstrates that only the HA of variant V100 that has a novel glycosylation site at amino acid residue 63 interacts differently with a specific monoclonal antibody, HC100(63), depending upon the state of antigen glycosylation.
A/England/878/69(H3) Hong Kong Variant. In influenza epidemics in 1969, viruses were isolated that were antigenically similar but distinguishable from the initial Hong Kong virus of 1968. The prototype of these viruses is A/England/878/69 and the amino acid sequence of its HA was reported by Sleigh et al. (20) . There are four amino acid sequence differences between the HA1 polypeptide chains of X-31 and A/England/878/69: substitutions of Asn for Asp at residue 63, Asp for Asn at residue 81, Asp for Gly at residue 144, and Val for Ile at residue 182. As in V100 described above, the substitution at residue 63 introduces a site for glycosylation, and to assess the effect of this sequence change on the antigenicity of A/England/878/69, we analyzed its HA in hemagglutination inhibition and immunoprecipitation reactions with monoclonal antibodies. The results in Table 1 indicated that the amino acid sequence changes at residues 63 and 144 both influence the antigenicity of A/England/ 878/69 HA since the virus fails to react with either HC100(63), which recognizes residue 63, or HC3(144), which recognizes residue 144. Other antigenic regions of X-31 and A/England/ 878/69 appear from this test to be similar, although the sequence change at position 81 may also be antigenically sig- Proc. Nati Acad Sci. USA 81 (1984) cells were used as controls for these experiments, and X-31 HA produced in cells incubated with or without tunicamycin was precipitated by the antibody (lanes 8 and 6) . These results are consistent with the conclusion that, as in the case of V100, the HA of A/England/878/69 is specifically prevented from reacting with antibody HC100(63) by the carbohydrate side chain linked to genic modification of the HA by a carbohydrate chain can be made for one of these sites of glycosylation. Fig. SA shows the coordinates of the oligosaccharide attached at residue 165 in the X-31 (1968) HA structure; it is clear that this oligosaccharide chain would block access of antibodies to the surface of the molecule between residues 166 and 168. Accordingly no variation either in strains isolated from patients between 1968 and 1982 or in variants selected by monoclonal antibodies has been observed in this region (165-168) of HAs of the Hong Kong (H3 subtype) viruses (4, 5, 21, 22 ). In contrast, the HA of A/PR/8/34 of the H1 subtype has no glycosylation sites in this region and an analysis of monoclonal antibody-selected antigenic variants has shown that amino acids 165, 166, and 167 can be recognized by monoclonal antibodies (Fig. 5B) (7) . It therefore seems reasonable to conclude from this example and the information presented here that the presence of oligosaccharide side chains can modify the antigenic structure of a HA by effectively masking regions of the molecule that may be antigenic in the HAs of viruses that lack the appropriate glycosylation site.
